HCM — HUTCHMED (China) Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid CapSucker Stock
- £2.05bn
- £1.27bn
- $356.13m
- 39
- 13
- 21
- 13
REG - Hutchmed China Ltd - Total Voting Rights
AnnouncementREG - Hutchmed China Ltd - Blocklisting Six Monthly Return
AnnouncementREG - Hutchmed China Ltd - HUTCHMED to Announce 2022 Half-Year Results
AnnouncementRCS - Hutchmed China Ltd - TAZVERIK® Approved in Hainan Pilot Zone
AnnouncementREG - Hutchmed China Ltd - LTIP and Share Options
AnnouncementREG - Hutchmed China Ltd - Appointment of Non–Executive Director
AnnouncementREG - Hutchmed China Ltd - HUTCHMED Receives CRL from the US FDA
AnnouncementREG - Hutchmed China Ltd - Annual General Meeting Poll Results
AnnouncementREG - Hutchmed China Ltd - Vesting of awards under Long Term Incentive Plan
AnnouncementREG - Hutchmed China Ltd - Update on Status under HFCAA
AnnouncementREG - Hutchmed China Ltd - 2021 Annual Report and Notice of AGM
AnnouncementREG - Hutchmed China Ltd - Update on Status under HFCAA
AnnouncementREG - Hutchmed China Ltd - Vesting of awards under Long Term Incentive Plan
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Receives $15m Milestone from AstraZeneca
AnnouncementRCS - Hutchmed China Ltd - Publication of Form 20-F
AnnouncementREG - Hutchmed China Ltd - Retirement of CEO and appointment of new CEO
AnnouncementREG - Hutchmed China Ltd - Full Year Results and Business Updates
AnnouncementRCS - Hutchmed China Ltd - Approval to Commercialize ELUNATE® in Macau
AnnouncementREG - Hutchmed China Ltd - HUTCHMED to Announce 2021 Final Results
Announcement